Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-11

Clinical Trial Update: Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion

View source ↗

Summary

This clinical trial update reports on the use of Ozurdex (dexamethasone intravitreal implant) in patients with macular edema due to retinal vein occlusion; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Macular Edema, Retinal Vein Occlusion | Status: COMPLETED | Results posted: 2016-02-11